NASDAQ · PNTG

The Pennant Group, Inc.

$41.34 +$0.18 (+0.44%) 1D After hours

Key Metrics

$1.43B
Market cap
47.19×
P/E · TTM
$1.02B
Revenue · TTM
$30.32M
Net income
EPS · TTM $0.86
Dividend yield
Free cash flow $50.77M
Beta · 1Y 0.47
EBITDA · TTM $57.60M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 7
    The stock moved +9.8% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, May 7
  • Feb 27
    The stock moved +10.6% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Feb 27

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$1.43B
Enterprise value
Shares outstanding34.8M
52-wk range$21.73 – $42.55
Avg volume · 20D196.0K
Net cash
Book value / share$11.06
IndustryServices-Health Services
ExchangeNASDAQ
About The Pennant Group, Inc.
IPO dateSep 19, 2019
Employees9700

Pennant Group Inc is engaged in providing healthcare services to patients of all ages, including the growing senior population, in the United States.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E47.19
P/S1.40
P/FCF28.19
EV/EBITDA
EV/Sales
Graham №$14.64

Profitability

Gross
Operating 4.7%
Net 3.0%
FCF 5.0%
ROE / ROIC 8.6% · —

Financial Health

Current ratio1.19
Quick ratio
Debt / equity0.44
Debt / EBITDA 2.95
Net cash
Working capital$24.25M

Cash Flow · TTM

Operating CF $66.12M
Capex −$15.35M
Free cash flow $50.77M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

3 / 9
Weak fundamentals · 3 of 9 signals passing

Altman Z-Score

2.9
Grey zone (1.81–2.99) · monitor

Graham Number vs Price

$14.64 vs $41.34
Trades 2.8× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings